Survival Outcomes Among Older Adults (Oa) Receiving Second-Line Therapy for Metastatic Crc (Mcrc): 5,289 Patients (Pts) from the Arcad Clinical Trials Program.
AuthID
P-00S-VCH
P-00S-VCH
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service